Daniel L Kisner - Net Worth and Insider Trading
Daniel L Kisner Net Worth
The estimated net worth of Daniel L Kisner is at least $123,368 dollars as of 2024-11-13. Daniel L Kisner is the Director of Zynerba Pharmaceuticals Inc and owns about 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $98,511. Daniel L Kisner is the Director of Dynavax Technologies Corp and owns about 1,500 shares of Dynavax Technologies Corp (DVAX) stock worth over $20,250. Daniel L Kisner is also the Director of Conatus Pharmaceuticals Inc and owns about 7,145 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $4,001. Besides these, Daniel L Kisner also holds Oncternal Therapeutics Inc (ONCT) . Details can be seen in Daniel L Kisner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel L Kisner has not made any transactions after 2023-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel L Kisner
Daniel L Kisner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel L Kisner owns 7 companies in total, including Histogen Inc (HSTO) , Oncternal Therapeutics Inc (ONCT) , and Zynerba Pharmaceuticals Inc (ZYNE) among others .
Click here to see the complete history of Daniel L Kisner’s form 4 insider trades.
Insider Ownership Summary of Daniel L Kisner
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HSTO | Histogen Inc | 2014-02-07 | director |
ONCT | Oncternal Therapeutics Inc | 2020-07-21 | director |
ZYNE | Zynerba Pharmaceuticals Inc | 2023-06-14 | director |
2013-10-30 | director | ||
2012-07-30 | director | ||
2015-01-01 | director | ||
2004-05-14 | director |
Daniel L Kisner Latest Holdings Summary
Daniel L Kisner currently owns a total of 4 stocks. Among these stocks, Daniel L Kisner owns 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of June 14, 2023, with a value of $98,511 and a weighting of 79.85%. Daniel L Kisner owns 1,500 shares of Dynavax Technologies Corp (DVAX) as of October 30, 2013, with a value of $20,250 and a weighting of 16.41%. Daniel L Kisner also owns 7,145 shares of Conatus Pharmaceuticals Inc (CNAT) as of April 8, 2015, with a value of $4,001 and a weighting of 3.24%. The other 1 stocks Oncternal Therapeutics Inc (ONCT) have a combined weighting of 0.49% among all his current holdings.
Latest Holdings of Daniel L Kisner
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZYNE | Zynerba Pharmaceuticals Inc | 2023-06-14 | 75,778 | 1.30 | 98,511 |
DVAX | Dynavax Technologies Corp | 2013-10-30 | 1,500 | 13.50 | 20,250 |
CNAT | Conatus Pharmaceuticals Inc | 2015-04-08 | 7,145 | 0.56 | 4,001 |
ONCT | Oncternal Therapeutics Inc | 2020-07-21 | 500 | 1.21 | 605 |
Holding Weightings of Daniel L Kisner
Daniel L Kisner Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel L Kisner has made a total of 2 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 115 shares on June 14, 2023, which brought Daniel L Kisner around $40.
According to the SEC Form 4 filings, Daniel L Kisner has made a total of 0 transactions in Dynavax Technologies Corp (DVAX) over the past 5 years. The most-recent trade in Dynavax Technologies Corp is the acquisition of 1,000 shares on October 30, 2013, which cost Daniel L Kisner around $10,800.
According to the SEC Form 4 filings, Daniel L Kisner has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 4,000 shares on April 8, 2015, which cost Daniel L Kisner around $23,000.
More details on Daniel L Kisner's insider transactions can be found in the Insider Trading History of Daniel L Kisner table.Insider Trading History of Daniel L Kisner
- 1
Daniel L Kisner Trading Performance
GuruFocus tracks the stock performance after each of Daniel L Kisner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel L Kisner is -5.98%. GuruFocus also compares Daniel L Kisner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel L Kisner within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel L Kisner's insider trading performs compared to the benchmark.
Performance of Daniel L Kisner
Daniel L Kisner Ownership Network
Ownership Network List of Daniel L Kisner
Ownership Network Relation of Daniel L Kisner
Daniel L Kisner Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Daniel L Kisner is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Daniel L Kisner Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel L Kisner. You might contact Daniel L Kisner via mailing address: 2292 Faraday Avenue, Carlsbad Ca 92008.